Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality;Yoǧun bakιm ünitelerinde saptanan Candida enfeksiyonlarιnιn epidemiyolojik özellikleri ve mortaliteye etki eden risk faktörleri

Mikrobiyoloji Bulteni

Volumn 42, Issue 3, 2008, Pages 451-461

  Acar, Ali ^a   Öncül, Oral ^a   Küçükardali, Yaşar ^a   Özyurt, Mustafa ^a   Haznedaroǧlu, Tuncer ^a   Çavuşlu, Şaban ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Candida species; Candidemia; Intensive care units; Risk factor

Indexed keywords

ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANDIDIASIS; CARDIOVASCULAR DISEASE; CHILD; COMORBIDITY; CROSS INFECTION; DIABETES MELLITUS; FEMALE; FUNGEMIA; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TURKEY (REPUBLIC); URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; CARDIOVASCULAR DISEASES; CHILD; COMORBIDITY; CROSS INFECTION; DIABETES MELLITUS; FEMALE; FUNGEMIA; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS; TURKEY; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 52349111381     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Toya SP, Schraufnagel DE, Tzelepsi GE. Candiduria in intensive care units: association with heavy colonization and candidaemia. J Hosp Infect 2007; 66: 201-6.
2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin infect Dis 2004; 39: 309-17.
3. Olaechea PM, Palomar M, Leon-Gil C, et al. Economic impact of Candida colonization and Candida infection in the critically ill patient. Eur J Clin Microbiol Infect Dis 2004; 23: 323-30.
4. Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish University Hospital. Mycoses 2006; 49: 134-8.
5. Haznedaroglu T, Turhan V, Oncul O, Acar A, Cavuslu S, and Infection Study Group. Nosocomial infections in intensive care units of a training hospital with 1000-bed for one-year period of 2006: prospective study. (OC22) 37th World Congress on Military Medicine. May 20-25, 2007, Tunisia.
6. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-44.
7. Bougnoux ME, Kac G, Aegerter P, d'Enfert C, Fagon JY; CandiRea Study Group. Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 2007; 34: 292-9.
8. Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period. Mycoses 2006; 50: 52-7.
9. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21: 510-5.
10. Bakir M, Cerikcioglu N, Barton R, Yagci A. Epidemiology of candidemia in a Turkish tertiary care hospital. APMIS 2006; 114: 601-10.
11. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez-Mazarrasa C, Farinas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 22: 254-7.
12. Blumberg HM, Jarvis WR, Soucie JM, et al. Risk factors for candidal bloodstream infections in surgical intensive care units patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 2001; 33: 187-90.
13. Talluri G, Marella VK, Shirazian D, Wise GJ. Immune response in patients with persistent candiduria and occult candidemia. J Urol 1999; 162: 1361-4.
14. Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000; 19: 602-7.
15. Paganini H, Rodriquez Brieshcke T, Santos P, Seu S, Rosanova MT. Risk factors for nosocomial candidaemia: a case-control study in children. J Hosp Infect 2002; 50: 304-8.
16. Ben-Abraham R, Keller N, Teodorovitch N, et al. Predictors of adverse outcome from candidal infection in a tertiary care hospital. J Infect 2004; 49: 317-23.
17. Clark TA, Hajjeh R. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002; 15: 569-74.
18. Costa SF, Marinho I, Araujo EA, Manrique AE, Medeiros EA, Levin AS. Nosocomial fungaemia: a 2-year prospective study. J Hosp Infect 2000; 45: 69-72.